| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 67.7699 | 68 |
| GSM780708 | Untreated after 4 days (C2_1) | 65.6726 | 67 |
| GSM780709 | Untreated after 4 days (C3_1) | 80.6204 | 72 |
| GSM780719 | Untreated after 4 days (C1_2) | 54.6272 | 59 |
| GSM780720 | Untreated after 4 days (C2_2) | 56.2994 | 61 |
| GSM780721 | Untreated after 4 days (C3_2) | 74.8836 | 70 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 58.6964 | 63 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 73.892 | 70 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 67.6121 | 68 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 64.6901 | 67 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 85.1967 | 73 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 60.6458 | 65 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 83.7379 | 72 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 60.2261 | 65 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 75.5004 | 71 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 87.3853 | 73 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 65.4922 | 67 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 68.6182 | 69 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 68.0368 | 68 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 95.0503 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 65.155 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 67.9181 | 68 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 71.9335 | 70 |